163 related articles for article (PubMed ID: 28992104)
1. A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs).
Shirotani K; Matsuo K; Ohtsuki S; Masuda T; Asai M; Kutoku Y; Ohsawa Y; Sunada Y; Kondo T; Inoue H; Iwata N
J Biochem; 2017 Dec; 162(6):391-394. PubMed ID: 28992104
[TBL] [Abstract][Full Text] [Related]
2. Multiple reaction monitoring assay based on conventional liquid chromatography and electrospray ionization for simultaneous monitoring of multiple cerebrospinal fluid biomarker candidates for Alzheimer's disease.
Choi YS; Lee KH
Arch Pharm Res; 2016 Mar; 39(3):390-7. PubMed ID: 26404792
[TBL] [Abstract][Full Text] [Related]
3. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease.
Schöndorf DC; Elschami M; Schieck M; Ercan-Herbst E; Weber C; Riesinger Y; Kalman S; Steinemann D; Ehrnhoefer DE
Stem Cell Res; 2019 Jan; 34():101351. PubMed ID: 30611016
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
[TBL] [Abstract][Full Text] [Related]
7. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
[TBL] [Abstract][Full Text] [Related]
8. Common proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer patients.
Chen M; Lee HK; Moo L; Hanlon E; Stein T; Xia W
J Proteomics; 2018 Jun; 182():21-33. PubMed ID: 29709615
[TBL] [Abstract][Full Text] [Related]
9. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
10. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
Tcw J
Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of acellular embryonic matrices on pluripotent stem cell expansion and neural differentiation.
Yan Y; Martin LM; Bosco DB; Bundy JL; Nowakowski RS; Sang QX; Li Y
Biomaterials; 2015 Dec; 73():231-42. PubMed ID: 26410789
[TBL] [Abstract][Full Text] [Related]
12. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
Yang J; Li S; He XB; Cheng C; Le W
Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
[TBL] [Abstract][Full Text] [Related]
15. Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates.
Choi YS; Hou S; Choe LH; Lee KH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():129-35. PubMed ID: 23735279
[TBL] [Abstract][Full Text] [Related]
16. Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.
Oeckl P; Steinacker P; von Arnim CA; Straub S; Nagl M; Feneberg E; Weishaupt JH; Ludolph AC; Otto M
J Proteome Res; 2014 Nov; 13(11):4518-25. PubMed ID: 25091646
[TBL] [Abstract][Full Text] [Related]
17. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
[TBL] [Abstract][Full Text] [Related]
18. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
[TBL] [Abstract][Full Text] [Related]
20. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
Lee C; Willerth SM; Nygaard HB
Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
